Login
September 21, 2022 1:00 pm Virtual
SEPTEMBER 21, 1:00 PM ET
“The Inflation Reduction Act” includes a number of significant prescription drug-related provisions, including a new drug price negotiation program in Medicare, inflation rebates in Medicare Part B and Part D, and a redesign of the Medicare Part D benefit, with a new patient out-of-pocket cap of $2,000.
Join BIO leadership as well as experts from the Hogan Lovells Life Sciences & Health Care team for overviews with Q&A on these newly enacted provisions.
Register/Info